These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17981480)
1. Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies. Lund JR; Paoloni M; Kurzman I; Padilla M; Argyle DJ Vet J; 2008 Aug; 177(2):192-7. PubMed ID: 17981480 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of telomerase-targeted therapies in canine cancer cell lines. Argyle DJ; McKevitt T; Gault E; Nasir L Vet Comp Oncol; 2004 Dec; 2(4):214-21. PubMed ID: 19379295 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity. Qian X; Cheng J; Chen A; Wang Y; Tao Y; Cao J; Feng Z Oncol Rep; 2008 Feb; 19(2):575-81. PubMed ID: 18202810 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference. Li S; Nosrati M; Kashani-Sabet M Methods Mol Biol; 2007; 405():113-31. PubMed ID: 18369821 [TBL] [Abstract][Full Text] [Related]
5. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies. Keith WN; Bilsland A; Hardie M; Evans TR Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826 [TBL] [Abstract][Full Text] [Related]
6. Telomeres and telomerase: Biological and clinical importance in dogs. Nasir L Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127 [TBL] [Abstract][Full Text] [Related]
7. Telomerase as an anti-cancer drug target: will it fulfil its early promise? Newbold RF Anticancer Drug Des; 1999 Aug; 14(4):349-54. PubMed ID: 10625927 [TBL] [Abstract][Full Text] [Related]
8. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related]
9. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y; Shen K; Yu JR Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307 [TBL] [Abstract][Full Text] [Related]
10. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331 [TBL] [Abstract][Full Text] [Related]
11. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype. Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483 [TBL] [Abstract][Full Text] [Related]
12. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma. Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833 [TBL] [Abstract][Full Text] [Related]
13. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A. Mook OR; Baas F; de Wissel MB; Fluiter K Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236 [TBL] [Abstract][Full Text] [Related]
14. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma. De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129 [TBL] [Abstract][Full Text] [Related]
15. The human and canine TERT promoters function equivalently in human and canine cells. Arendt ML; Nasir L; Morgan IM Vet Comp Oncol; 2010 Dec; 8(4):310-6. PubMed ID: 21062413 [TBL] [Abstract][Full Text] [Related]
16. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo. Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA. Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184 [TBL] [Abstract][Full Text] [Related]
19. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]. Song Y; Shen K; He CX Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518 [TBL] [Abstract][Full Text] [Related]
20. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter]. Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]